000 01535 a2200409 4500
005 20250516220127.0
264 0 _c20150123
008 201501s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.1687
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJanku, Filip
245 0 0 _aIdentification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.
_h[electronic resource]
260 _bOncotarget
_cMay 2014
300 _a3012-22 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aPhosphatidylinositol 3-Kinases
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
_xmetabolism
650 0 4 _aSignal Transduction
_xphysiology
650 0 4 _aTOR Serine-Threonine Kinases
_xmetabolism
700 1 _aKaseb, Ahmed O
700 1 _aTsimberidou, Apostolia M
700 1 _aWolff, Robert A
700 1 _aKurzrock, Razelle
773 0 _tOncotarget
_gvol. 5
_gno. 10
_gp. 3012-22
856 4 0 _uhttps://doi.org/10.18632/oncotarget.1687
_zAvailable from publisher's website
999 _c23920481
_d23920481